


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Recently Viewed
MLYS
Mineralys Therapeutics
LIDR
Aeye
HLT
Hilton Worldwide Holdings
CEVA
CEVA
RMBS
Rambus
Most Trending
-1.94%
-0.09%
+4.05%
+2.22%
-1.09%
MLYS
Mineralys Therapeutics
$31.31
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
MLYS Price Performance
$37.35 (-16.17%)
$40.56 (-22.81%)
$15.22 (+105.72%)
$10.05 (+211.54%)
MLYS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLYS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLYS Street Sentiment is extremely bullish and have negative views on the near-term outlook
MLYS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
MLYS
Mineralys Therapeutics
31.31
-1.94%
LIDR
Aeye
1.99
+0.51%
HLT
Hilton Worldwide Holdings
296.46
+2.23%
CEVA
CEVA
23.60
+4.84%
RMBS
Rambus
125.93
+14.38%
What is MLYS current stock price?
What are MLYS stock strengths?
What is MLYS Risk Level?
What is MLYS market cap and volume?
What is MLYS current Stock IQ?
Should I buy MLYS stock right now?
Is MLYS a Strong Buy right now?
What does a 'Strong Buy' rating mean for MLYS?
What does a 'Strong Sell' rating mean for MLYS?
What factors influence MLYS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Recently Viewed
MLYS
Mineralys Therapeutics
LIDR
Aeye
HLT
Hilton Worldwide Holdings
CEVA
CEVA
RMBS
Rambus
Most Trending
-1.94%
-0.09%
+4.05%
+2.22%
-1.09%
MLYS
Mineralys Therapeutics
Current Price
$31.31
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Recently Viewed
MLYS
Mineralys Therapeutics
31.31
-1.94%
LIDR
Aeye
1.99
+0.51%
HLT
Hilton Worldwide Holdings
296.46
+2.23%
CEVA
CEVA
23.60
+4.84%
RMBS
Rambus
125.93
+14.38%

MLYS Price Performance
$37.35 (-16.17%)
$40.56 (-22.81%)
$15.22 (+105.72%)
$10.05 (+211.54%)
MLYS Analysts Opinion
MLYS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
MLYS Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
MLYS Street Sentiment is extremely bullish and have negative views on the near-term outlook
MLYS has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels
Nov 12, 2025
Reiterate
Overweight
Wells Fargo
Nov 12, 2025
Reiterate
Buy
HC Wainwright & Co.
Oct 30, 2025
Reiterate
Buy
HC Wainwright & Co.
MLYS Stock IQ
MLYS Latest Analysis
Relative Strength Alert For Mineralys Therapeutics . Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which me
Today
Noteworthy Wednesday Option Activity: MLYS MPW PZZA. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Mineralys Therapeutics Inc (Symbol: MLYS) where a total volume of 92683 contracts has been traded thus far today a contract volume which is representative of
Wed Jan 7, 2026
Mineralys Builds Momentum As Lorundrostat Nears FDA Review And Expands Into New Indications . (RTTNews) - Mineralys Therapeutics Inc. (MLYS) has several upcoming milestone events this year related to its lead candidate Lorundrostat a selective aldosterone synthase inhibitor.
Wed Jan 7, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
MLYS Stock trends
MLYS Stock performance
MLYS Stock analysis
MLYS investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.